Variant report

Variant	nsv520755
Chromosome Location	chr6:36702284-36713720
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:206)
CpG islands
(count:122)
Chromatin interactive
region (count:34)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:206 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr6:36708418-36708433	HepG2	liver:	n/a	n/a
2	BHLHE40	chr6:36708380-36708460	K562	blood:	n/a	n/a
3	BHLHE40	chr6:36708312-36708547	GM12878	blood:	n/a	n/a
4	BHLHE40	chr6:36710914-36711102	HepG2	liver:	n/a	n/a
5	CEBPB	chr6:36702907-36703264	IMR90	lung:	n/a	n/a
6	CREB1	chr6:36713614-36713996	K562	blood:	n/a	chr6:36713808-36713821
7	CTCF	chr6:36702860-36703010	GM12873	blood:	n/a	n/a
8	CTCF	chr6:36702540-36702690	AG10803	skin:	n/a	n/a
9	CTCF	chr6:36703660-36703810	AG04450	lung:	n/a	n/a
10	CTCF	chr6:36702860-36703010	BJ	skin:	n/a	n/a
11	CTCF	chr6:36702923-36703042	GM19240	blood:	n/a	n/a
12	CTCF	chr6:36702900-36703052	Lung_OC	lung:	n/a	n/a
13	CTCF	chr6:36702880-36703030	HPAF	blood vessel:	n/a	n/a
14	CTCF	chr6:36702660-36702810	GM12872	blood:	n/a	n/a
15	CTCF	chr6:36702920-36703070	AG09309	skin:	n/a	n/a
16	CTCF	chr6:36702960-36703110	GM12872	blood:	n/a	n/a
17	CTCF	chr6:36702900-36703050	HCPEpiC	choroid plexus:	n/a	n/a
18	CTCF	chr6:36702900-36703050	GM12878	blood:	n/a	n/a
19	CTCF	chr6:36702893-36703008	Fibrobl	skin:	n/a	n/a
20	CTCF	chr6:36702860-36703010	WI-38	lung:	n/a	n/a
21	CTCF	chr6:36702900-36703050	AG09319	gingival:	n/a	n/a
22	CTCF	chr6:36702880-36703030	HL-60	blood:	n/a	n/a
23	CTCF	chr6:36702860-36703010	HVMF	connective:	n/a	n/a
24	CTCF	chr6:36702799-36703127	GM12878	blood:	n/a	n/a
25	CTCF	chr6:36702971-36703033	ProgFib	skin:	n/a	n/a
26	CTCF	chr6:36702904-36703009	GM12878	blood:	n/a	n/a
27	CTCF	chr6:36702900-36703050	HPF	lung:	n/a	n/a
28	CTCF	chr6:36702400-36702550	HEK293	kidney:	n/a	chr6:36702494-36702512 chr6:36702501-36702509
29	CTCF	chr6:36703660-36703810	HCPEpiC	choroid plexus:	n/a	n/a
30	CTCF	chr6:36702900-36703050	HMEC	breast:	n/a	n/a
31	CTCF	chr6:36703560-36703710	NHDF-neo	bronchial:	n/a	n/a
32	CTCF	chr6:36702940-36703090	GM12869	blood:	n/a	n/a
33	CTCF	chr6:36702900-36703050	AG04449	skin:	n/a	n/a
34	CTCF	chr6:36702929-36703025	GM10248	blood:	n/a	n/a
35	CTCF	chr6:36702900-36703050	GM12866	blood:	n/a	n/a
36	CTCF	chr6:36702880-36703030	HUVEC	blood vessel:	n/a	n/a
37	CTCF	chr6:36702880-36703030	NHEK	skin:	n/a	n/a
38	CTCF	chr6:36703700-36703850	HBMEC	blood vessel:	n/a	n/a
39	CTCF	chr6:36702860-36703010	HRPEpiC	eye:	n/a	n/a
40	CTCF	chr6:36703740-36703890	AoAF	blood vessel:	n/a	n/a
41	CTCF	chr6:36702493-36702563	H1-hESC	embryonic stem cell:	n/a	chr6:36702494-36702512 chr6:36702501-36702509
42	CTCF	chr6:36702560-36702710	GM12874	blood:	n/a	n/a
43	CTCF	chr6:36702820-36702970	GM12864	blood:	n/a	n/a
44	CTCF	chr6:36703080-36703230	GM12867	blood:	n/a	n/a
45	CTCF	chr6:36702920-36703070	AG09319	gingival:	n/a	n/a
46	CTCF	chr6:36702855-36703111	IMR90	lung:	n/a	n/a
47	CTCF	chr6:36702849-36703071	GM19239	blood:	n/a	n/a
48	CTCF	chr6:36702880-36703030	GM12872	blood:	n/a	n/a
49	CTCF	chr6:36702880-36703030	HCPEpiC	choroid plexus:	n/a	n/a
50	CTCF	chr6:36702860-36703010	HPF	lung:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:36709214-36709264	MCF-7	breast:	n/a
2	chr6:36703127-36703177	HUVEC	blood vessel:	n/a
3	chr6:36703127-36703177	HRE	kidney:	n/a
4	chr6:36703127-36703177	MCF10A-Er-Src	breast:	n/a
5	chr6:36709214-36709264	AG10803	skin:	n/a
6	chr6:36703127-36703177	AoSMC	blood vessel:	n/a
7	chr6:36703127-36703177	Caco-2	colon:	n/a
8	chr6:36709214-36709264	SK-N-SH_RA	brain:	n/a
9	chr6:36709214-36709264	PFSK-1	brain:	n/a
10	chr6:36709214-36709264	AG09319	gingival:	n/a
11	chr6:36703127-36703177	K562	blood:	n/a
12	chr6:36703127-36703177	MCF-7	breast:	n/a
13	chr6:36709214-36709264	HMEC	breast:	n/a
14	chr6:36703127-36703177	PANC-1	pancreas:	n/a
15	chr6:36709214-36709264	HRPEpiC	eye:	n/a
16	chr6:36703127-36703177	PrEC	prostate:	n/a
17	chr6:36703127-36703177	HCT-116	colon:	n/a
18	chr6:36709214-36709264	HCF	heart:	n/a
19	chr6:36703127-36703177	IMR90	lung:	fetal
20	chr6:36703127-36703177	GM06990	blood:	n/a
21	chr6:36703127-36703177	ECC-1	luminal epithelium:	n/a
22	chr6:36703127-36703177	PFSK-1	brain:	n/a
23	chr6:36703127-36703177	LNCaP	prostate:	n/a
24	chr6:36703127-36703177	SK-N-SH_RA	brain:	n/a
25	chr6:36709214-36709264	AG04449	skin:	fetal
26	chr6:36709214-36709264	NH-A	brain:	n/a
27	chr6:36709214-36709264	HRCEpiC	kidney:	n/a
28	chr6:36709214-36709264	GM12878	blood:	n/a
29	chr6:36709214-36709264	HEEpiC	esophagus:	n/a
30	chr6:36703127-36703177	AG04449	skin:	fetal
31	chr6:36709214-36709264	K562	blood:	n/a
32	chr6:36703127-36703177	H1-hESC	embryonic stem cell:	embryo
33	chr6:36703127-36703177	BE2_C	brain:	n/a
34	chr6:36703127-36703177	U87	brain:	n/a
35	chr6:36709214-36709264	LNCaP	prostate:	n/a
36	chr6:36703127-36703177	ovcar-3	ovarian:	n/a
37	chr6:36703127-36703177	GM12892	blood:	n/a
38	chr6:36709214-36709264	PrEC	prostate:	n/a
39	chr6:36703127-36703177	RPTEC	kidney:	n/a
40	chr6:36703127-36703177	GM12891	blood:	n/a
41	chr6:36709214-36709264	NHBE	bronchial:	n/a
42	chr6:36709214-36709264	GM06990	blood:	n/a
43	chr6:36703127-36703177	SK-N-SH	brain:	n/a
44	chr6:36709214-36709264	PANC-1	pancreas:	n/a
45	chr6:36709214-36709264	ECC-1	luminal epithelium:	n/a
46	chr6:36709214-36709264	AG09309	skin:	n/a
47	chr6:36703127-36703177	HRCEpiC	kidney:	n/a
48	chr6:36703127-36703177	HIPEpiC	eye:	n/a
49	chr6:36703127-36703177	GM19239	blood:	n/a
50	chr6:36703127-36703177	HepG2	liver:	n/a

(count:34 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:36711266..36713245-chr6:36715954..36717794,2	MCF-7	breast:
2	chr6:36561849..36563615-chr6:36700031..36702846,2	K562	blood:
3	chr6:36645227..36647717-chr6:36711034..36713028,2	K562	blood:
4	chr6:36706791..36710785-chr6:36712838..36716064,4	MCF-7	breast:
5	chr6:36671517..36673727-chr6:36709746..36712131,2	K562	blood:
6	chr6:36706267..36708533-chr6:36712946..36714916,2	K562	blood:
7	chr6:36705988..36708979-chr6:36709402..36712073,2	K562	blood:
8	chr6:36708140..36710606-chr6:36718569..36720077,2	MCF-7	breast:
9	chr6:36706145..36708888-chr6:36709331..36711123,2	MCF-7	breast:
10	chr6:36704975..36706910-chr6:36710272..36712382,2	MCF-7	breast:
11	chr6:36563235..36565666-chr6:36712198..36714107,2	K562	blood:
12	chr6:36681851..36683948-chr6:36705203..36707828,2	K562	blood:
13	chr6:36583432..36585248-chr6:36700120..36704013,3	MCF-7	breast:
14	chr6:36575316..36577688-chr6:36710838..36712742,2	K562	blood:
15	chr6:36704975..36706910-chr6:36710272..36712382,2	MCF-7	breast:
16	chr6:36588827..36591407-chr6:36708568..36710825,2	MCF-7	breast:
17	chr6:36658059..36660618-chr6:36709664..36711830,2	MCF-7	breast:
18	chr6:36706791..36710785-chr6:36712838..36716064,4	MCF-7	breast:
19	chr6:36708918..36710565-chr6:36712727..36715586,2	K562	blood:
20	chr6:36706267..36708533-chr6:36712946..36714916,2	K562	blood:
21	chr6:36710588..36713306-chr6:36722738..36724865,2	MCF-7	breast:
22	chr6:36708174..36711394-chr6:36720287..36721932,3	MCF-7	breast:
23	chr6:36646178..36648267-chr6:36708912..36712169,4	MCF-7	breast:
24	chr6:36692869..36694899-chr6:36700775..36703080,2	MCF-7	breast:
25	chr6:36705103..36707775-chr6:36711430..36713266,2	MCF-7	breast:
26	chr6:36635018..36637044-chr6:36710933..36713268,2	K562	blood:
27	chr6:36705988..36708979-chr6:36709402..36712073,2	K562	blood:
28	chr6:36705103..36707775-chr6:36711430..36713266,2	MCF-7	breast:
29	chr6:36710180..36712510-chr6:36716987..36718768,2	K562	blood:
30	chr6:36695657..36698030-chr6:36700581..36702478,2	K562	blood:
31	chr6:36708918..36710565-chr6:36712727..36715586,2	K562	blood:
32	chr6:36706145..36708888-chr6:36709331..36711123,2	MCF-7	breast:
33	chr6:36682976..36685028-chr6:36712488..36714251,2	MCF-7	breast:
34	chr6:36646077..36648615-chr6:36711852..36713395,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000220349	TF binding region
ENSG00000220349	CpG island
ENSG00000255587	chromatin interactions
ENSG00000263894	chromatin interactions
ENSG00000124762	chromatin interactions
ENSG00000112081	chromatin interactions

Extended variants
information (count: 515 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:515 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs236452	chr6:36702284-36702285	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs554844671	chr6:36702307-36702308	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs146055022	chr6:36702310-36702311	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs190939353	chr6:36702360-36702361	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs34260075	chr6:36702372-36702373	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs236451	chr6:36702379-36702380	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs576499836	chr6:36702381-36702382	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs77394127	chr6:36702387-36702388	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs552727081	chr6:36702388-36702389	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs236450	chr6:36702407-36702408	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs543000313	chr6:36702412-36702413	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs182883024	chr6:36702437-36702438	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs74572930	chr6:36702494-36702495	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs116094703	chr6:36702593-36702594	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs569305130	chr6:36702598-36702599	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs565400087	chr6:36702648-36702649	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs140201582	chr6:36702654-36702655	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs186609825	chr6:36702666-36702667	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs62406605	chr6:36702774-36702775	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs236449	chr6:36702843-36702844	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs545391929	chr6:36702849-36702850	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs530054759	chr6:36702862-36702863	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs143894399	chr6:36702867-36702868	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs569579863	chr6:36702877-36702878	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs536866415	chr6:36702898-36702899	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs113707476	chr6:36702907-36702908	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs570294978	chr6:36702921-36702922	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs534458314	chr6:36702943-36702944	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs553032543	chr6:36702954-36702955	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs574355066	chr6:36702960-36702961	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs535391103	chr6:36702966-36702967	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs74796013	chr6:36702976-36702977	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs191850860	chr6:36703017-36703018	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs184035137	chr6:36703064-36703065	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs115486000	chr6:36703065-36703066	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs187629205	chr6:36703079-36703080	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs41439445	chr6:36703095-36703096	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs200467192	chr6:36703119-36703120	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs559756868	chr6:36703128-36703129	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs530055775	chr6:36703158-36703159	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs548150529	chr6:36703159-36703160	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs192076458	chr6:36703161-36703162	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs542271330	chr6:36703175-36703176	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
44	rs530745439	chr6:36703233-36703234	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs557159152	chr6:36703277-36703278	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs80296862	chr6:36703295-36703296	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs370336762	chr6:36703305-36703306	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs546389359	chr6:36703342-36703343	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs150027583	chr6:36703404-36703405	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs375194892	chr6:36703487-36703488	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Lung cancer	19153074	CNVD
Ovarian cancer	21720365	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:435 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:36689200-36702400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
2	chr6:36690400-36702600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
3	chr6:36694000-36703000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr6:36695800-36702600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr6:36695800-36702800	Weak transcription	Gastric	stomach
6	chr6:36696000-36702600	Weak transcription	NHEK	skin
7	chr6:36697200-36702400	Weak transcription	Adipose Nuclei	Adipose
8	chr6:36697200-36702400	Weak transcription	NHDF-Ad	bronchial
9	chr6:36697400-36702600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr6:36697600-36702600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr6:36697600-36702600	Weak transcription	HUVEC	blood vessel
12	chr6:36697800-36702400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr6:36699200-36703200	Weak transcription	HUES64 Cell Line	embryonic stem cell
14	chr6:36699200-36703400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
15	chr6:36699600-36702400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
16	chr6:36700600-36702400	Weak transcription	Right Atrium	heart
17	chr6:36700800-36702400	Weak transcription	Fetal Brain Male	brain
18	chr6:36701200-36702400	Enhancers	Fetal Muscle Leg	muscle
19	chr6:36701200-36702400	Weak transcription	GM12878-XiMat	blood
20	chr6:36702000-36702800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
21	chr6:36702000-36704000	Enhancers	Primary monocytes fromperipheralblood	blood
22	chr6:36702200-36702400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr6:36702200-36702400	Enhancers	Primary neutrophils fromperipheralblood	blood
24	chr6:36702200-36702400	Enhancers	Monocytes-CD14+_RO01746	blood
25	chr6:36702200-36702600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr6:36702200-36702600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr6:36702200-36702600	Bivalent Enhancer	Fetal Stomach	stomach
28	chr6:36702200-36702600	Enhancers	NHLF	lung
29	chr6:36702200-36702800	Enhancers	Primary B cells from cord blood	blood
30	chr6:36702200-36702800	Enhancers	Primary B cells from peripheral blood	blood
31	chr6:36702200-36702800	Enhancers	Skeletal Muscle Female	skeletal muscle
32	chr6:36702200-36702800	Enhancers	Stomach Smooth Muscle	stomach
33	chr6:36702200-36703800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr6:36702200-36703800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
35	chr6:36702200-36703800	Enhancers	Spleen	Spleen
36	chr6:36702200-36704000	Enhancers	Esophagus	oesophagus
37	chr6:36702200-36704000	Enhancers	Sigmoid Colon	Sigmoid Colon
38	chr6:36702200-36704200	Enhancers	Stomach Mucosa	stomach
39	chr6:36702200-36704800	Enhancers	Lung	lung
40	chr6:36702400-36702600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr6:36702400-36702600	Enhancers	Breast Myoepithelial Primary Cells	Breast
42	chr6:36702400-36702600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr6:36702400-36702600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr6:36702400-36702600	Enhancers	Colonic Mucosa	Colon
45	chr6:36702400-36702600	Enhancers	Rectal Mucosa Donor 29	rectum
46	chr6:36702400-36702600	Enhancers	Rectal Smooth Muscle	rectum
47	chr6:36702400-36702800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr6:36702400-36702800	Enhancers	Primary T helper cells PMA-I stimulated	--
49	chr6:36702400-36702800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr6:36702400-36702800	Enhancers	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links